Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Journal of Neuro-Oncology
|
December 23, 2025
Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)
Guy N Ron, Ilan G Ron, Halit Kantor, et al.
American Journal of Clinical Oncology
|
October 24, 2002
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups
Ilan G Ron, Nely Wigler, Riva Borovik, et al.
Chest
|
November 16, 2016
Stable-State Midrange-Proadrenomedullin Level Is a Strong Predictor of Mortality in Patients With COPD
Maaike C Zuur-Telgen, Marjolein G J Brusse-Keizer, Paul D L P M VanderValk, et al.
Clinical Drug Investigation
|
February 6, 2007
Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study
David Sarid, Ilan G Ron, Fani Sperber, et al.
Chest
|
August 6, 2014
Response
Maaike C Zuur-Telgen, Marjolein G J Brusse-Keizer, Job van der Palen, et al.
Anticancer Research
|
November 27, 2008
Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53
David Sarid, Ilan G Ron, Lior Shoshan, et al.
American Journal of Clinical Oncology
|
July 28, 2001
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study
I G Ron, N Wigler, R Borovik, et al.
Journal of Skin Cancer
|
February 1, 2013
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma
M Klein, M Lotem, T Peretz, et al.
Physical Review Letters
|
June 21, 2014
Search at the Mainz Microtron for light massive gauge bosons relevant for the muon g-2 anomaly
H Merkel, P Achenbach, C Ayerbe Gayoso, et al.
Science (New York, N.Y.)
|
May 31, 2008
Probing cold dense nuclear matter
R Subedi, R Shneor, P Monaghan, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Journal of Neuro-Oncology
|
December 23, 2025
Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)
Guy N Ron, Ilan G Ron, Halit Kantor, et al.
American Journal of Clinical Oncology
|
October 24, 2002
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups
Ilan G Ron, Nely Wigler, Riva Borovik, et al.
Chest
|
November 16, 2016
Stable-State Midrange-Proadrenomedullin Level Is a Strong Predictor of Mortality in Patients With COPD
Maaike C Zuur-Telgen, Marjolein G J Brusse-Keizer, Paul D L P M VanderValk, et al.
Clinical Drug Investigation
|
February 6, 2007
Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study
David Sarid, Ilan G Ron, Fani Sperber, et al.
Chest
|
August 6, 2014
Response
Maaike C Zuur-Telgen, Marjolein G J Brusse-Keizer, Job van der Palen, et al.
Anticancer Research
|
November 27, 2008
Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53
David Sarid, Ilan G Ron, Lior Shoshan, et al.
American Journal of Clinical Oncology
|
July 28, 2001
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study
I G Ron, N Wigler, R Borovik, et al.
Journal of Skin Cancer
|
February 1, 2013
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma
M Klein, M Lotem, T Peretz, et al.
Physical Review Letters
|
June 21, 2014
Search at the Mainz Microtron for light massive gauge bosons relevant for the muon g-2 anomaly
H Merkel, P Achenbach, C Ayerbe Gayoso, et al.
Science (New York, N.Y.)
|
May 31, 2008
Probing cold dense nuclear matter
R Subedi, R Shneor, P Monaghan, et al.
Page
of 9